# Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.

> **NCT00356915** · PHASE3 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 1381 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** Itraconazole 100mg capsules
- **DRUG:** Itraconazole 200mg tablets
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT00356915
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 1381 (ACTUAL)
- **Last updated:** 2017-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356915, "Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00356915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*